 |
InterPro: IPR002202 Hydroxymethylglutaryl-CoA reductase, class I/II, catalytic
Protein matches
|
UniProtKB Matches: 981 proteins |
|
Accession
|
IPR002202 HMG_CoA_Rdtase_cat |
Type
|
Domain |
Signatures
|
|
InterPro Relationships
|
|
Children
|
IPR004554 Hydroxymethylglutaryl-CoA reductase, class I, catalytic
|
|
Found in
|
IPR004553 Hydroxymethylglutaryl-CoA reductase, class II/archaeal class I
IPR004816 Hydroxymethylglutaryl-CoA reductase, class I, metazoan
|
|
Contains
|
IPR009023 Hydroxymethylglutaryl-CoA reductase, class I/II, NAD/NADP-binding
IPR009029 Hydroxymethylglutaryl-CoA reductase, class I/II, substrate-binding
|
GO Term annotation
|
|
Process
|
GO:0015936 coenzyme A metabolic process
GO:0055114 oxidation reduction
|
|
Function
|
GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity
GO:0050662 coenzyme binding
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Synonym(s): 3-hydroxy-3-methylglutaryl-coenzyme A reductase, HMG-CoA reductase.
There are two distinct classes of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase enzymes: class I consists of eukaryotic and most archaeal enzymes (EC:1.1.1.34), while class II consists of prokaryotic enzymes (EC:1.1.1.88) [1, 2].
Class I HMG-CoA reductases catalyse the NADP-dependent synthesis of mevalonate from 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). In vertebrates, membrane-bound HMG-CoA reductase is the rate-limiting enzyme in the biosynthesis of cholesterol and other isoprenoids. In plants, mevalonate is the precursor of all isoprenoid compounds [2]. The reduction of HMG-CoA to mevalonate is regulated by feedback inhibition by sterols and non-sterol metabolites derived from mevalonate, including cholesterol. In archaea, HMG-CoA reductase is a cytoplasmic enzyme involved in the biosynthesis of the isoprenoids side chains of lipids [3]. Class I HMG-CoA reductases consist of an N-terminal membrane domain (lacking in archaeal enzymes), and a C-terminal catalytic region. The catalytic region can be subdivided into three domains: an N-domain (N-terminal), a large L-domain, and a small S-domain (inserted within the L-domain). The L-domain binds the substrate, while the S-domain binds NADP.
Class II HMG-CoA reductases catalyse the reverse reaction of class I enzymes, namely the NAD-dependent synthesis of HMG-CoA from mevalonate and CoA [4]. Some bacteria, such as Pseudomonas mevalonii, can use mevalonate as the sole carbon source. Class II enzymes lack a membrane domain. Their catalytic region is structurally related to that of class I enzymes, but it consists of only two domains: a large L-domain and a small S-domain (inserted within the L-domain). As with class I enzymes, the L-domain binds substrate, but the S-domain binds NAD (instead of NADP in class I).
This entry represents the catalytic region found in both class I and II HMG-CoA reductases. The catalytic region from both classes share a common overall structural fold, despite low sequence identities of 14-20%. Class I eukaryotic enzymes contain an extra N-terminal domain not represented by this entry.
|
Structural links
|
|
Database links
|
|
Example proteins
|
P04035 3-hydroxy-3-methylglutaryl-coenzyme A reductase
P12683 3-hydroxy-3-methylglutaryl-coenzyme A reductase 1
P14773 3-hydroxy-3-methylglutaryl-coenzyme A reductase
P14891 3-hydroxy-3-methylglutaryl-coenzyme A reductase 1
Q01237 3-hydroxy-3-methylglutaryl-coenzyme A reductase
More proteins
Example Proteins Key
| InterPro entry accession number/name and structure databases |
Colour code |
| IPR009023 |
Hydroxymethylglutaryl-CoA reductase, class I/II, NAD/NADP-binding |
 |
| IPR004554 |
Hydroxymethylglutaryl-CoA reductase, class I, catalytic |
 |
| IPR002202 |
Hydroxymethylglutaryl-CoA reductase, class I/II, catalytic |
 |
| IPR000731 |
Sterol-sensing 5TM box |
 |
| IPR009029 |
Hydroxymethylglutaryl-CoA reductase, class I/II, substrate-binding |
 |
| IPR004816 |
Hydroxymethylglutaryl-CoA reductase, class I, metazoan |
 |
|
SWISS-MODEL |
 |
|
PDB Chain |
 |
|
ModBase |
 |
|
SCOP Domain |
 |
|
CATH Domain |
 |
|
Additional Reading
|
|
Basson ME, Thorsness M, Finer-Moore J, Stroud RM, Rine J.
Structural and functional conservation between yeast and human 3-hydroxy-3-methylglutaryl coenzyme A reductases, the rate-limiting enzyme of sterol biosynthesis.
Mol. Cell. Biol. 8 1988 3797-808
[PubMed: 3065625]
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=3065625&action=stream&blobtype=pdf
|
|
Beach MJ, Rodwell VW.
Cloning, sequencing, and overexpression of mvaA, which encodes Pseudomonas mevalonii 3-hydroxy-3-methylglutaryl coenzyme A reductase.
J. Bacteriol. 171 1989 2994-3001
[PubMed: 2656635]
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=2656635
|
|
Darnay BG, Wang Y, Rodwell VW.
Identification of the catalytically important histidine of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
J. Biol. Chem. 267 1992 15064-70
[PubMed: 1634543]
http://intl.jbc.org/cgi/reprint/267/21/15064.pdf
|
|
Pfefferkorn JA, Choi C, Song Y, Trivedi BK, Larsen SD, Askew V, Dillon L, Hanselman JC, Lin Z, Lu G, Robertson A, Sekerke C, Auerbach B, Pavlovsky A, Harris MS, Bainbridge G, Caspers N.
Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors.
Bioorg. Med. Chem. Lett. 17 2007 4531-7
[PubMed: 17574411]
http://dx.doi.org/10.1016/j.bmcl.2007.05.097
|
|
Lam WL, Doolittle WF.
Mevinolin-resistant mutations identify a promoter and the gene for a eukaryote-like 3-hydroxy-3-methylglutaryl-coenzyme A reductase in the archaebacterium Haloferax volcanii.
J. Biol. Chem. 267 1992 5829-34
[PubMed: 1556098]
http://intl.jbc.org/cgi/reprint/267/9/5829.pdf
|
|
Pfefferkorn JA, Song Y, Sun KL, Miller SR, Trivedi BK, Choi C, Sorenson RJ, Bratton LD, Unangst PC, Larsen SD, Poel TJ, Cheng XM, Lee C, Erasga N, Auerbach B, Askew V, Dillon L, Hanselman JC, Lin Z, Lu G, Robertson A, Olsen K, Mertz T, Sekerke C, Pavlovsky A, Harris MS, Bainbridge G, Caspers N, Chen H, Eberstadt M.
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors.
Bioorg. Med. Chem. Lett. 17 2007 4538-44
[PubMed: 17574412]
http://dx.doi.org/10.1016/j.bmcl.2007.05.096
|
|
Caelles C, Ferrer A, Balcells L, Hegardt FG, Boronat A.
Isolation and structural characterization of a cDNA encoding Arabidopsis thaliana 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Plant Mol. Biol. 13 1989 627-38
[PubMed: 2491679]
http://dx.doi.org/10.1007/BF00016018
|
|
Luskey KL, Stevens B.
Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation.
J. Biol. Chem. 260 1985 10271-7
[PubMed: 2991281]
http://intl.jbc.org/cgi/content/abstract/260/18/10271
|
|
Lawrence CM, Rodwell VW, Stauffacher CV.
Crystal structure of Pseudomonas mevalonii HMG-CoA reductase at 3.0 angstrom resolution.
Science 268 1995 1758-62
[PubMed: 7792601]
http://www.sciencemag.org/cgi/content/abstract/268/5218/1758
|
|
Chin DJ, Gil G, Russell DW, Liscum L, Luskey KL, Basu SK, Okayama H, Berg P, Goldstein JL, Brown MS.
Nucleotide sequence of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, a glycoprotein of endoplasmic reticulum.
Nature 308 1984 613-7
[PubMed: 6546784]
http://dx.doi.org/10.1038/308613a0
|
|
Park WK, Kennedy RM, Larsen SD, Miller S, Roth BD, Song Y, Steinbaugh BA, Sun K, Tait BD, Kowala MC, Trivedi BK, Auerbach B, Askew V, Dillon L, Hanselman JC, Lin Z, Lu GH, Robertson A, Sekerke C.
Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.
Bioorg. Med. Chem. Lett. 18 2008 1151-6
[PubMed: 18155906]
http://dx.doi.org/10.1016/j.bmcl.2007.11.124
|
|
Tabernero L, Rodwell VW, Stauffacher CV.
Crystal structure of a statin bound to a class II hydroxymethylglutaryl-CoA reductase.
J. Biol. Chem. 278 2003 19933-8
[PubMed: 12621048]
http://dx.doi.org/10.1074/jbc.M213006200
|
|
Pfefferkorn JA, Choi C, Larsen SD, Auerbach B, Hutchings R, Park W, Askew V, Dillon L, Hanselman JC, Lin Z, Lu GH, Robertson A, Sekerke C, Harris MS, Pavlovsky A, Bainbridge G, Caspers N, Kowala M, Tait BD.
Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia.
J. Med. Chem. 51 2008 31-45
[PubMed: 18072721]
http://dx.doi.org/10.1021/jm070849r
|
|
Chye ML, Kush A, Tan CT, Chua NH.
Characterization of cDNA and genomic clones encoding 3-hydroxy-3-methylglutaryl-coenzyme A reductase from Hevea brasiliensis.
Plant Mol. Biol. 16 1991 567-77
[PubMed: 1714317]
http://dx.doi.org/10.1007/BF00023422
|
|